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Background: Intensive Care Units (ICUs) accommodate the most seriously ill patients in a relatively confined environment. 
Increased duration of stay, increased number of indwelling and invasive devices and prolonged or inappropriate use of 
antibiotics are common features of ICUs, with consequent or associated increase in selection of multi-resistant pathogens, 
morbidity and mortality. 
Objectives: To determine the identity and antimicrobial resistance pattern of organisms commonly associated with infections in 
the ICU of the hospital. 
Method: A retrospective study of Intensive Care Units (ICU) infections in NHA over a three-year period January 1st, 2010 to 
December 31st, 2012 was conducted through review and analysis of laboratory data. 
Results: Data for 79specimens were fully analysed; 35(44%) from urine, 17 (22%) from blood, 6 (8%) from tracheal specimens 
and 8 (10%) from wound. Forty-one (52%)of the specimens yielded growth;16 (20%) from urine, 8 (10%) from wound, 6 (8%) 
from tracheal specimens,3(4%) from blood and others 8(10%). 14(34%) out of the 41 isolates were Escherichia coli, 8 (20%) 
Pseudomonas aeruginosa, 6 (15%) were Staphylococcus aureus and 6 (15%) Klebsiella pneumoniae. Three (4%) of the specimens 
yielded mixed growths while another 3 (4%) yielded Candida species.  Sensitivity of E. coli to third generation cephalosporins 
ranged from 62-72%and 90% to imipenem. For Klebsiella pneumoniae it was 67-75% to third generation cephalosporins and 
100% to imipenem. Pseudomonas aeruginosa was 71% and 83% sensitive to ceftazidime and imipenem respectively. 
Staphylococcus aureus was 67% and 83% sensitive to amoxicillin-clavulanate and imipenem respectively. Susceptibility of all 
these isolates to fluoroquinolones and aminoglycosides remained poor.  
Conclusion: The isolates from the ICU were same as common in clinical specimens. There was wide variability in resistance 
with a tendency to increase over time. This trend needs to be monitored while antibiotic stewardship should be emphasised.  
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RÉSUMÉ 
Contexte: Les services de soins intensifs accueillent les patients les plus gravement malades dans un 
environnement relativement confiné. Une durée accrue du séjour, un nombre accru de demeurants et d’appareils 
et une utilisation prolongée ou inappropriée d'antibiotiques sont des caractéristiques communes de soins 
intensifs, avec l’augmentation conséquente ou associés de la sélection des agents pathogènes multi-résistants, de 
la morbidité et de la mortalité. 
Méthodes: Une étude rétrospective des infections de services de soins intensifs dans l’Hôpital National d’Abuja a 
été menée pour l'examen et l'analyse des données de laboratoire sur une période de trois ans allant du 1er Janvier 
2010 au 31 Décembre 2012. 
Résultats: Les données de 79 échantillons ont été entièrement analysés; 35 (44%) échantillons d'urine, 17 (22%) 
échantillons du sang, 6 (8%)  à partir d'échantillons trachéaux et 8 (10%) à partir de la plaie. Quarante-et-un (52%) 
des échantillons ont produit une croissance: 16 (20%) d'urine, 8 (10%) de la plaie, 6 (8%) à partir d'échantillons 
trachéaux, 3 (4%) à partir du sang et 8  (10 %) à partir d'autres type d’échantillons. 14 (34%) des 41 isolats étaient 
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de Escherichia coli, 8 (20%) Pseudomonas aeruginosa, six (15%) étaient des Staphylococcus aureus et 6 (15%) 
Klebsiella pneumoniae. Trois (4%) des spécimens ont montré une croissance mixte tandis que les trois autres (4%) 
ont donné les espèces de Candida. La sensibilité de E. coli aux céphalosporines de troisième génération variait de 
62 à 72% et 90% pour l'imipenème. Pour Klebsiella pneumoniae, 67-75% de souches étaient sensibles aux 
céphalosporines de troisième génération et 100% à l'imipenème. 71% et 83% de Pseudomonas aeruginosa ont été 
sensibles respectivement à la ceftazidime et à  l’imipenème. 67% et 83% de Staphylococcus aureus étaient 
sensibles respectivement à l'amoxicilline+ acide clavulanique et à l’imipenème. La sensibilité de toutes ces 
souches aux fluoroquinolones et aux aminoglycosides est restée médiocre. 
Conclusion: Les souches de services de soins intensifs étaient les mêmes que les principales souches cliniques. Il 
y avait une large variabilité dans la résistance tendant à  augmenter avec le temps. Cette tendance doit être 
surveillée pendant que la gestion d’antibiotique devrait être accentuée. 
Mots clés: Services de Soins Intensifs, Infections nosocomiales, sensibilité d’antibiotique.
INTRODUCTION 
Many tertiary hospitals in Nigeria have developed 
critical care facilities for the care of the critically ill 
patient.(1). The intensive care unit (ICU) of the 
National Hospital, Abuja (NHA) is an eight bed 
facility in a 200-beded centre. This represents 4% of 
the total bed space in the hospital. This percentage 
varies from one country to another, ranging from 1-
2% in the UK, 1.7% in New Zealand to 6-11% in the 
USA (2-4) 
Infection is often the cause of ICU admissions (5-6), 
and four types account for most ICU infections; 
namely pneumonia (usually ventilator 
associated),urinary tract infection (UTI) (usually 
catheter associated), primary bloodstream infection 
(BSI) (usually associated with the use of an 
intravascular device) and surgical site 
infections(SSI)(7) 
The common pathogens include Staphylococcus 
aureus, Pseudomonas aeruginosa, Candida species, 
Escherichia coli and Klebsiella species, often 
predisposed to by invasive applications and devices, 
and patients’ clinical conditions (8,9).These infections 
account substantially for the high mortality in ICUs.  
Antimicrobial resistance constitutes a major challenge 
in the management of ICU infections, and these often 
emerged from selective pressure due to increased, 
and sometimes inappropriate antibiotic use and 
transmission via health workers. . Greater than 60% 
of ICU patients receive broad spectrum antibiotics at 
some time during their hospitalization, and up to 60% 
of antibiotic use in hospitals is inappropriate or 
unnecessary (10,11). Microbiological cultures and 
antibiotic sensitivity testing are central to rapid and 
accurate diagnosis and treatment, which improves 
outcomes and reduces resistance. It also guides 
empiric antibiotic therapy.  
Prevention of infection in the ICU is fundamental and 
can be achieved through good antimicrobial use and 
infection control practices, including hand hygiene 
(12) It is therefore important that physicians strike a 
balance between patients’ safety, and the desire to 
reduce mortality and antibiotics resistance. In our 
environment the profile of the common organisms 
associated with infections in the ICU is not clear. This 
study was therefore, designed to determine the 
common pathogens in our environment and their 
antibiotics susceptibility profiles so as to guide 
therapy and achieve reduction in mortality and 
resistance development.  
METHOD 
The NHA is a tertiary medical centre providing 
medical services to Abuja and its surrounding states 
of Kogi, Nasarawa, Niger, Kaduna and Benue. A 
retrospective study of adult Intensive Care Units 
(ICU) infections over three years in NHA was 
conducted for the period of 1st January 2010 to 31st 
December 2012. The record of all specimens 
submitted to the medical microbiology laboratory 
within this period were analysed including 
evaluation of their microbial susceptibility pattern. 
Those with incomplete record were excluded. 
Data obtained for analysis included; age, sex, 
specimen type, isolated organisms and their 
corresponding antibiotic susceptibility pattern.  
Briefly, in our laboratory clinical specimens are 
collected in sterile plastic containers, swabs or others 
as appropriate for the relevant anatomic sites and are 
usually processed as soon as they are received. The 
macroscopic appearances of the samples are noted 
and then inoculated onto appropriate culture media. 
Where necessary direct smears of specimen are made 
on clean glass slide, fixed and stained by Gram’s 
standard method (13). The plates are then incubated 
at 37oC in ambient air for 16-24hours, but chocolate 
agar plates are incubated in a candle light jar. 
Cultures are examined for growth thereafter. In some 
cases where there is no growth, cultures may be re-
incubated for another 24 hours before they are 
discarded as having no growth. The colonies are 
identified using standard methods13,14. Antimicrobial 
drug susceptibility of the isolates are usually tested 
by the modified Kirby-Bauer technique and results 
interpreted according to the Clinical Laboratory 
Standards Institute-CLSI Guideline 15.  
 
RESULTS 
79 specimen were fully analysed; 35(44%) from urine, 
17 (22%) from blood, 6 (8%) from tracheal specimens 
and 8 (10%) from wound. 41(52%) of the specimens 
yielded growth; 16 (20%) from urine, 8 (10%) from 
wound, 6 (8%) from tracheal specimens and 3(4%) 
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from blood. 14 (34%) out of the 41 isolates were 
Escherichia coli, 8 (20%) Pseudomonas aeruginosa, 6 
(15%) were Staphylococcus aureus and 6 (15%) 
Klebsiella pneumoniae. Three (3%) of the specimens 
yielded mixed growths while another 3 (4%) yielded 
Candida species (Table 1). One of the blood isolates 
was Salmonella typhi.  The ages of patients in this 
study ranged from 37-68, with a mean of 51 years. 
There were 44(56%) males and 34(44%) females. 
 





Sensitivity of E. coli to third generation 
cephalosporins ranges from 62-72%and 90% to 
imipenem. For Klebsiella pneumoniae it was 67-75% to 
third generation cephalosporins and 100% to 
imipenem. Pseudomonas aeruginosa was 71% and 83% 
sensitive to ceftazidime and imipenem respectively. 
Staphylococcus aureus was 67% and 83% sensitive to 
amoxicillin-clavulanate and imipenem respectively. 
Sensitivity of all these isolates to fluoroquinolones 
and aminoglycosides were poor (Table 2).  
 
DISCUSSION 
The National Hospital Abuja has an eight bedded, 
well equipped ICU, which partly explains the 
relatively low number of samples received in the 
laboratory from the unit. The other prominent factor 
is connected with the financial inability of the 
majority of the patients admitted into the unit to 
afford the cost of investigations. The 79 samples 
included in the study yielded 41 isolates over a period 
of three years. As established in previous studies, the 
small numbers of isolates recovered from the ICU 
specimens tend to limit objective discussions due to 
its potential to overstate ICU resistance problems 
based on a small number of resistant isolates13-15. This 
appears to be the trend in most ICUs as most patients 
presenting to the unit would have had substantial 
doses of variable antibiotics.  
Notwithstanding these limitations, it is worthy of 
note that most specimens processed in this study 
were urine, blood, wound and respiratory, 
corresponding to the to the most common infections 
encountered in the ICU, namely urinary tract, blood 
stream, wound and respiratory infections (16). 
Together they yielded over 80% of the isolates, 
dominated by organisms previously identified to be 
associated with nosocomial infections and invasive 
procedures (8,9), both of which are common in the 
ICU. 
 
The two main Enterobacteriacae, Klebsiella pneumoniae 
and Escherichia coli, isolated in our ICU demonstrated 
high and moderate sensitivity to imipenem and the 
third generation cephalosporins/amikacin 
respectively, and high resistance to amoxicillin-
clavulanate, fluoroquinolones, second generation 
cephalosporin and gentamicin. This pattern suggests 
high prevalence of extended spectrum β-lactamase 
(ESBL) production and low level carbapenemase 
production among the isolates. Pseudomonas 
aeruginosa isolates only showed moderate sensitivity 
to imipenem and ceftazidime, similar to similar 
finding in a previous study (17); the likely implication 
of this pattern is that while the choice for empiric 
therapy may be substantially limited, there may be a 
tendency to over-use the carbapenems, which will 
further compromise their use as drugs of last resort in 
our environment at the moment. In all, the 
predominance of Pseudomonas aeruginosa, Escherichia 
coli, Klebsiella pneumoniae and Staphylococcus aureus 
amongst all isolates from the ICU is similar to the 
profile seen in a previous study (18). 
The choice of chemotherapy for staphylococcal 
infections may appear even more challenging as the 
isolated strains displayed only moderate sensitivity to 
amoxicillin-clavulanate and imipenem. There was 
also isolation of Enterococcus and Candida spp from 
urine, in agreement with result of a previous study18.  
Generally, the moderate to high resistance and 
multidrug resistance seen in the ICU isolates, subject 
to the limitations earlier mentioned, is in agreement 
with what had been observed with ICU isolates 
(8,19).This is due to the over-use of antibiotics, which 
invariably puts the organisms on selective pressure. 
To address this and reduce the rate of resistance 
development choice of antibiotics must be based on 
established guidelines and sound knowledge of 
pharmacokinetics and pharmacodynamics of the 
drugs. Since synchronized adherence to locally 
evolved guidelines within a hospital has been 
associated with stable antibiotic resistance patterns.20, 
antibiotics stewardship should be practiced, while 
further studies are needed to determine the 
prevalence of ESBL and carbapenemase production as 
well as prevalence of methicillin resistant 




Specimens No No of Isolates 
Blood 17 (22%) 3(4%) 
Urine 35(44%) 16(20%) 
Wound 8 (10%) 8 (10%) 
Tracheal 6 (8%) 6 (8%) 
High Vaginal 
Swab 
4(5%) 2 (3%) 
Other 9(11%) 6 (7%) 
Total 79(100) 41(52%) 
   
 
 











No Tested % 
Sensitive 






AMC 13 31 0 0 Nil nil 6 67 
CTX 12 67 6 67 7 14 6 17 
CAZ 11 72 4 75 7 71 5 0 
CRO 13 69 6 67 Nil Nil 4 0 
XM 14 29 2 0 Nil Nil 6 50 
GN 14 36 5 60 6 43 6 33 
AK 8 75 6 83 7 57 6 50 
CIP 13 43 5 60 7 57 5 40 
OFX 9 44 nil Nil Nil Nil 2 50 
IMP 10 90 5 100 8 86 6 83 
AMC: amoxicillin-clavulanate; CTX: cefotaxime; CAZ: ceftazidime; CRO: ceftriaxone; XM: cefuroxime; GN: gentamicin; AK: 
amikacin; CIP: ciprofloxacin; OFX: ofloxacin; IMP: imipenem 
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